What's new?
The application of Angiotensin Receptor Blockers (ARBs) in treating cardiovascular conditions has garnered significant trust among physicians primarily through empirical evidence from monotherapy trials. Valsartan, one prototypical ARB, exhibits a substantial body of evidence underscoring its efficacy in managing hypertension and heart failure. This article elucidates Valsartan's role as aShow More
Hypertension, often termed the "silent killer," is a significant public health challenge due to its asymptomatic nature. The absence of symptoms means that many individuals remain unaware of their condition, leading to undiagnosed hypertension, which substantially increases morbidity and mortality rates. This article aims to inform healthcare professionals about the dangers of asymptomaticShow More
Filipinos, often celebrated as modern heroes for their contributions both domestically and internationally, face significant health challenges that threaten their productivity and family income. Hypertension, a silent but potent enemy, is a leading risk factor for cardiovascular morbidity and mortality, particularly prevalent among Asian populations. 1
The ImpactShow More